Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
Clinical trial NCT05962450 · UNKNOWN
Trial details
- NCT number
- NCT05962450
- Sponsor
- Beijing YouAn Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2025-08-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.